SHARE
Human Milk Oligosaccharides Market

Human Milk Oligosaccharides - Global Market Outlook (2018-2027)

4.6 (25 reviews)
Published: January 2020 ID: SMRC18760
4.6 (25 reviews)
Published: January 2020 ID: SMRC18760

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Human Milk Oligosaccharides Market is accounted for $17.90 million in 2018 and is expected to reach $98.05 million by 2027 growing at a CAGR of 21%. Growing application of HMOs in functional foods and increasing demand in infant formula is likely to boost the growth of the market. However, the high cost of production is hindering the growth of the global human milk oligosaccharides market is likely to hamper the profit boundaries.

Human milk oligosaccharides (HMOs) act as prebiotics in human body and help in maintaining gut health. They promote bacterial growth, especially bifidobacteria genus, in the gut, which helps in improving metabolic activity. The antimicrobial protection and prebiotic functions of the product allow them to be used in various food products including pharmaceutical and medicinal food and infant formulas.

Based on the application, the infant formulas are anticipated to grow at the fastest rate during the forecast period. This is attributable to the health benefits associated with the infant formulas such as maintaining gut microbiota and inhibition of pathogen in infants.

By geography, North America recorded the largest share of the global human milk oligosaccharides market revenues. The presence of several major infant formula and baby food manufacturers and technological advancements in the region can be considered major factors driving the market growth.

Some of the key players in the Human Milk Oligosaccharides Market include ZuChem Inc, Medolac Laboratories, Jennewein Biotechnologie GmbH, Inbiose NV, Glycosyn LLC, Glycom A/S and Elicityl S A.    
 
Products Covered:
• Sialyllactose (6’SL)
• Sialyllactose (3’SL)
• Lacto-N-tetraose (LNT)
• Lacto-N-neotetraose (LNnT)
• Fucosyllactose (3’FL)
• Fucosyllactose (2’FL)

Applications Covered:
• Functional Food & Beverages 
• Food Supplements 
• Infant Formula 
• Health Ingredients for Human and Animal 
• Other applications 
    
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand
o South Korea      
o Rest of Asia Pacific      
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa


What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary


2 Preface   
 2.1 Abstract  
 2.2 Stake Holders 
 2.3 Research Scope 
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources 
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
    
3 Market Trend Analysis 
 3.1 Introduction 
 3.2 Drivers  
 3.3 Restraints 
 3.4 Opportunities 
 3.5 Threats  
 3.6 Product Analysis 
 3.7 Application Analysis
 3.8 Emerging Markets 
 3.9 Futuristic Market Scenario
    
4 Porters Five Force Analysis 
 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry 
    
5 Global Human Milk Oligosaccharides Market, By Product
 5.1 Introduction 
 5.2 Sialyllactose (6’SL) 
 5.3 Sialyllactose (3’SL) 
 5.4 Lacto-N-tetraose (LNT)
 5.5 Lacto-N-neotetraose (LNnT)
 5.6 Fucosyllactose (3’FL)
 5.7 Fucosyllactose (2’FL)
    
6 Global Human Milk Oligosaccharides Market, By Application
 6.1 Introduction 
 6.2 Functional Food & Beverages
 6.3 Food Supplements 
 6.4 Infant Formula 
 6.5 Health Ingredients for Human and Animal
 6.6 Other Applications 
    
7 Global Human Milk Oligosaccharides Market, By Geography
 7.1 Introduction 
 7.2 North America 
  7.2.1 US 
  7.2.2 Canada 
  7.2.3 Mexico 
 7.3 Europe  
  7.3.1 Germany 
  7.3.2 UK 
  7.3.3 Italy 
  7.3.4 France 
  7.3.5 Spain 
  7.3.6 Rest of Europe
 7.4 Asia Pacific 
  7.4.1 Japan 
  7.4.2 China 
  7.4.3 India 
  7.4.4 Australia 
  7.4.5 New Zealand
  7.4.6 South Korea
  7.4.7 Rest of Asia Pacific
 7.5 South America 
  7.5.1 Argentina
  7.5.2 Brazil 
  7.5.3 Chile 
  7.5.4 Rest of South America
 7.6 Middle East & Africa
  7.6.1 Saudi Arabia
  7.6.2 UAE 
  7.6.3 Qatar 
  7.6.4 South Africa
  7.6.5 Rest of Middle East & Africa
    
8 Key Developments  
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
 8.2 Acquisitions & Mergers
 8.3 New Product Launch
 8.4 Expansions 
 8.5 Other Key Strategies
    
9 Company Profiling  
 9.1 ZuChem Inc 
 9.2 Medolac Laboratories
 9.3 Jennewein Biotechnologie GmbH
 9.4 Inbiose NV 
 9.5 Glycosyn LLC 
 9.6 Glycom A/S 
 9.7 Elicityl S A 


List of Tables   
1 Global Human Milk Oligosaccharides Market Outlook, By Region (2017-2027) ($MN)
2 Global Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
3 Global Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
4 Global Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
5 Global Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
6 Global Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
7 Global Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
8 Global Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
9 Global Human Milk Oligosaccharides Market Outlook, By Application (2017-2027) ($MN)
10 Global Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
11 Global Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
12 Global Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
13 Global Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
14 Global Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
15 North America Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
16 North America Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
17 North America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
18 North America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
19 North America Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
20 North America Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
21 North America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
22 North America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
23 North America Human Milk Oligosaccharides Market Outlook, By Application (2017-2027) ($MN)
24 North America Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
25 North America Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
26 North America Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
27 North America Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
28 North America Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
29 Europe Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
30 Europe Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
31 Europe Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
32 Europe Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
33 Europe Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
34 Europe Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
35 Europe Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
36 Europe Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
37 Europe Human Milk Oligosaccharides Market Outlook, By Application (2017-2027) ($MN)
38 Europe Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
39 Europe Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
40 Europe Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
41 Europe Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
42 Europe Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
43 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
44 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
45 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
46 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
47 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
48 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
49 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
50 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
51 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Application (2017-2027) ($MN)
52 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
53 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
54 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
55 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
56 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
57 South America Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
58 South America Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
59 South America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
60 South America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
61 South America Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
62 South America Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
63 South America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
64 South America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
65 South America Human Milk Oligosaccharides Market Outlook, By Application (2017-2027) ($MN)
66 South America Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
67 South America Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
68 South America Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
69 South America Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
70 South America Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
71 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
72 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
73 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
74 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
75 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
76 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
77 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
78 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
79 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Application (2017-2027) ($MN)
80 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
81 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
82 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
83 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
84 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials